LEINCO TECHNOLOGIES, INC.

Leinco Technologies, Inc. specializes in the development and production of highly specific monoclonal antibodies through advanced in-vivo genetic immunization techniques, primarily using knockout mouse models. Their core expertise lies in the manufacturing of diagnostic-grade biologics for research and defense applications, with a focus on proteins such as interferon-alpha/beta receptor alpha chain. The company demonstrates deep technical proficiency in immunogen design, hybridoma generation, and purification of high-affinity antibodies, positioning them as a niche provider of custom biologics for complex immunological targets. Their work in laboratory testing services further supports assay validation and quality control for diagnostic substances, ensuring traceability and reproducibility in sensitive applications. This dual capability in both production and analytical validation distinguishes them as an integrated biologics solutions provider rather than a conventional contract manufacturer. Leinco Technologies maintains a strong relationship with the Department of Defense, delivering mission-critical monoclonal antibodies for defense-related biomedical research and materiel requirements. Their work for the Department of Health and Human Services involves laboratory testing services, suggesting a complementary role in supporting public health diagnostics and biothreat preparedness. The consistency of engagement with DoD indicates a trusted partnership in developing countermeasures and diagnostic tools for emerging biological threats. The company’s primary industry focus is in in-vitro diagnostic substance manufacturing and testing laboratories, serving the defense and biomedical research sectors. Their specialization in genetically engineered antibody production for novel protein targets places them at the intersection of immunology, molecular biology, and diagnostic development, catering to agencies requiring bespoke biological reagents not available through commercial channels. Leinco Technologies, Inc. is a small business headquartered in Fenton, Missouri, with no federal certifications on record. Their geographic presence is centered in the Midwest, and they operate as a specialized contractor serving federal research and defense programs requiring high-complexity biologic manufacturing and analytical validation.